Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 Apr;32(4):1085–1087. doi: 10.1128/jcm.32.4.1085-1087.1994

Comparison of novel synthetic peptide-based DETECT-RUBELLA enzyme immunoassays with Enzygnost and IMx for detection of rubella-specific immunoglobulin G.

L Pedneault 1, M Zrein 1, L Robillard 1, F Landry 1, M Lacroix 1, J Joncas 1
PMCID: PMC267191  PMID: 8027318

Abstract

Enzyme immunoassays (EIAs) using synthetic peptides SP-E1 and SP-E1E2 (DETECT-RUBELLA [Bio-Chem]) were compared with two viral lysate-based EIAs (Enzygnost [Behring] and IMx [Abbott]) for the detection of rubella virus-specific immunoglobulin G antibodies. Sensitivities of 94.7, 100, 98.6, and 100% and specificities of 100, 97.4, 100, and 73.7% were found for the SP-E1, SP-E1E2, Enzygnost, and IMx EIAs, respectively.

Full text

PDF
1085

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott G. G., Safford J. W., MacDonald R. G., Craine M. C., Applegren R. R. Development of automated immunoassays for immune status screening and serodiagnosis of rubella virus infection. J Virol Methods. 1990 Feb;27(2):227–239. doi: 10.1016/0166-0934(90)90139-7. [DOI] [PubMed] [Google Scholar]
  2. Green K. Y., Dorsett P. H. Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies. J Virol. 1986 Mar;57(3):893–898. doi: 10.1128/jvi.57.3.893-898.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Herrmann K. L. Available rubella serologic tests. Rev Infect Dis. 1985 Mar-Apr;7 (Suppl 1):S108–S112. doi: 10.1093/clinids/7.supplement_1.s108. [DOI] [PubMed] [Google Scholar]
  4. Katow S., Sugiura A. Antibody response to individual rubella virus proteins in congenital and other rubella virus infections. J Clin Microbiol. 1985 Mar;21(3):449–451. doi: 10.1128/jcm.21.3.449-451.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lozzi L., Rustici M., Corti M., Cusi M. G., Valensin P. E., Bracci L., Santucci A., Soldani P., Spreafico A., Neri P. Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis. Arch Virol. 1990;110(3-4):271–276. doi: 10.1007/BF01311295. [DOI] [PubMed] [Google Scholar]
  6. Mitchell L. A., Zhang T., Ho M., Décarie D., Tingle A. J., Zrein M., Lacroix M. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J Clin Microbiol. 1992 Jul;30(7):1841–1847. doi: 10.1128/jcm.30.7.1841-1847.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Schaefer L. E., Dyke J. W., Meglio F. D., Murray P. R., Crafts W., Niles A. C. Evaluation of microparticle enzyme immunoassays for immunoglobulins G and M to rubella virus and Toxoplasma gondii on the Abbott IMx automated analyzer. J Clin Microbiol. 1989 Nov;27(11):2410–2413. doi: 10.1128/jcm.27.11.2410-2413.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Skurrie I. J., Head J. L., Garland S. M. Detection of rubella-specific immunoglobulin G: comparison of the enzyme-linked immunosorbent assay and an automated microparticle enzyme immunoassay (IMx). J Clin Microbiol. 1991 Aug;29(8):1752–1753. doi: 10.1128/jcm.29.8.1752-1753.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Terry G. M., Ho-Terry L., Londesborough P., Rees K. R. Localization of the rubella E1 epitopes. Arch Virol. 1988;98(3-4):189–197. doi: 10.1007/BF01322168. [DOI] [PubMed] [Google Scholar]
  10. Thomas H. I., Morgan-Capner P. Rubella-specific IgG subclass concentrations in sera using an enzyme-linked immunosorbent assay (ELISA): the effect of different sources of rubella antigen. Epidemiol Infect. 1988 Dec;101(3):599–604. doi: 10.1017/s0950268800029460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Trudel M., Nadon F., Séguin C., Amarouch A., Payment P., Gillam S. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody. J Virol Methods. 1985 Dec;12(3-4):243–250. doi: 10.1016/0166-0934(85)90135-1. [DOI] [PubMed] [Google Scholar]
  12. Wolinsky J. S., McCarthy M., Allen-Cannady O., Moore W. T., Jin R., Cao S. N., Lovett A., Simmons D. Monoclonal antibody-defined epitope map of expressed rubella virus protein domains. J Virol. 1991 Aug;65(8):3986–3994. doi: 10.1128/jvi.65.8.3986-3994.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wolinsky J. S., Sukholutsky E., Moore W. T., Lovett A., McCarthy M., Adame B. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain. J Virol. 1993 Feb;67(2):961–968. doi: 10.1128/jvi.67.2.961-968.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Zrein M., Joncas J. H., Pedneault L., Robillard L., Dwyer R. J., Lacroix M. Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination. J Clin Microbiol. 1993 Jun;31(6):1521–1524. doi: 10.1128/jcm.31.6.1521-1524.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES